Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Philippines FDA Slashes Generic Approval Timelines
Cuts Review From 120 To 45 Days As President Urges Lower Prices ‘Similar To India’
The FDA in the Philippines is cutting generic approval timelines • Source: Shutterstock
More from Regulation
More from Policy & Regulation